Acquisition by Jonathan Siegal of 937 shares of Vericel Corp subject to Rule 16b-3
VCEL Stock | USD 59.25 0.27 0.46% |
About 50% of Vericel Corp's institutional investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Vericel Corp Ord suggests that some traders are interested. Vericel Corp's investing sentiment shows overall attitude of investors towards Vericel Corp Ord.
Vericel |
Filed transaction by Vericel Corp Ord Officer: Principal Accounting Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Vericel Corp Fundamental Analysis
We analyze Vericel Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vericel Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vericel Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Vericel Corp is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Vericel Corp Ord Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vericel Corp stock to make a market-neutral strategy. Peer analysis of Vericel Corp could also be used in its relative valuation, which is a method of valuing Vericel Corp by comparing valuation metrics with similar companies.
Peers
Vericel Corp Related Equities
RVMD | Revolution Medicines | 5.25 | ||||
RGNX | Regenxbio | 5.05 | ||||
STOK | Stoke Therapeutics | 4.57 | ||||
DYN | Dyne Therapeutics | 4.43 | ||||
IPSC | Century Therapeutics | 3.66 | ||||
KROS | Keros Therapeutics | 2.99 | ||||
CYTK | Cytokinetics | 2.71 | ||||
CRNX | Crinetics Pharmaceuticals | 2.23 | ||||
MREO | Mereo BioPharma | 2.09 | ||||
RLAY | Relay Therapeutics | 1.34 | ||||
CMRX | Chimerix | 0.98 | ||||
MRUS | Merus BV | 0.19 | ||||
SNDX | Syndax Pharmaceuticals | 0.21 | ||||
BPMC | Blueprint Medicines | 0.24 | ||||
IDYA | Ideaya Biosciences | 0.25 | ||||
PLRX | Pliant Therapeutics | 0.74 | ||||
DAWN | Day One | 1.51 | ||||
XNCR | Xencor | 1.75 | ||||
CLGN | Collplant Biotechnologies | 2.34 | ||||
TERN | Terns Pharmaceuticals | 6.28 | ||||
XFOR | X4 Pharmaceuticals | 10.81 |
Check out Vericel Corp Hype Analysis, Vericel Corp Correlation and Vericel Corp Performance. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.